Brochures and Posters
Charles River Labs has acquired Pathoquest, strengthening its end-to-end biologics testing portfolio with Next Generation Sequencing (NGS). Our GMP-compliant, animal-free NGS assays for viral safety and genetic characterization enable a faster and safer release of biotherapies to patients. Learn More
Brochures
iDTECT® for
Vaccines
Flyer
iDTECT® for
Gene Therapies
Flyer
iDTECT® for
Cell Therapies
Flyer
iDTECT® for Biologics
Flyer
iDTECT® NGS Assays
Flyer
iDTECT® TRANSCRIPTOME
Flyer
iDTECT® VIROME
Flyer
iDTECT® IDENTITY
Flyer
iDTECT® INTEGRATION SITE ANALYSIS
Flyer
iDTECT® HLA GENOTYPING
Flyer
iDTECT® FOR CULTURED MEAT
Flyer
Application Notes
REPLACING THE MAP, HAP, RAP TESTS WITH iDTECT® TRANSCRIPTOME
Application Note
GMP Viral Vector and Plasmid Identity Testing
with iDTECT®
Application Note
Posters
Have We Finally Reached the End of in vitro Testing? Positioning NGS in your Biosafety Testing Strategy.
Poster
Unveiling Recombinant Cell Line Mysteries: Nanopore CAS9 Sequencing For Integration Site Analysis.
Poster
Contact us
U.S.
466 Devon Park Dr
Wayne, PA 19087
United States
Sign up for our latest news
Follow Us
France
+33 (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
Sign up for our latest news
Follow Us
How can PathoQuest help?
